Home > Balance Sheet > BAL PHARMA

BAL PHARMA
Total Non-Current Liabilities

    Back to Balance Sheet
BAL PHARMA is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
AD     Remove this Ad

BAL PHARMA Last 5 Year Total Non-Current Liabilities History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Total Non-Current Liabilities ₹38 Cr₹45 Cr₹38 Cr₹36 Cr₹34 Cr

What is the latest Total Non-Current Liabilities ratio of BAL PHARMA ?

The latest Total Non-Current Liabilities ratio of BAL PHARMA is ₹38 Cr based on Mar2025 Consolidated results.
Year Total Non-Current Liabilities
Mar2025₹38 Cr
Mar2024₹45 Cr
Mar2023₹38 Cr
Mar2022₹36 Cr
Mar2021₹34 Cr

How is Total Non-Current Liabilities of BAL PHARMA Trending?

Years Total Non-Current Liabilities % Change
Mar2025 ₹38 Cr
-14.36
Mar2024 ₹45 Cr
18.02
Mar2023 ₹38 Cr
4.32
Mar2022 ₹36 Cr
6.44
Mar2021 ₹34 Cr -

Compare Total Non-Current Liabilities of peers of BAL PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
BAL PHARMA ₹120.1 Cr 7.2% 5.1% -35.2% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹407,431.0 Cr -0.4% -0.1% -2% Stock Analytics
DIVIS LABORATORIES ₹163,772.0 Cr 0.9% -3% 0.8% Stock Analytics
TORRENT PHARMACEUTICALS ₹137,884.0 Cr 2% 1.7% 25.2% Stock Analytics
CIPLA ₹107,503.0 Cr -0.9% -7.2% -9.7% Stock Analytics
DR REDDYS LABORATORIES ₹105,798.0 Cr -0.6% 6.8% 2.7% Stock Analytics


BAL PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
BAL PHARMA

7.2%

5.1%

-35.2%

SENSEX

-1.1%

-1.2%

5.9%


You may also like the below Video Courses